PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 6 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics lance un processus de recherche de repreneurs dans le cadre de son redressement judiciaire. Appel d'offres ouvert jusqu'au 11 avril 2025 Appel D'offres Redressement Judiciaire Repreneurs Procédure PHAXIAM Therapeutics
BRIEF published on 03/06/2025 at 18:01, 1 year 6 months ago PHAXIAM Therapeutics entre en redressement judiciaire et retarde ses résultats financiers Retard Des Résultats Financiers Administrateur Judiciaire Suspension Des Échanges Mise Sous Séquestre De PHAXIAM Défis Biotechnologiques
BRIEF published on 03/06/2025 at 18:01, 1 year 6 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 6 months ago Informations privilégiées / Autres communiqués PHAXIAM annonce l'ouverture d'une procédure de redressement judiciaire et le report de la publication de ses résultats financiers 2024. La Société se place sous la protection du Tribunal de commerce de Lyon Résultats Financiers Tribunal De Commerce Redressement Judiciaire PHAXIAM Procédure
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 6 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 6 months ago Suspension de la Cotation de PHAXIAM Therapeutics Euronext Paris Biopharmaceutique Suspension Cotation PHAXIAM Therapeutics Infections Résistantes
BRIEF published on 03/06/2025 at 11:45, 1 year 6 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
PRESS RELEASE published on 03/06/2025 at 11:40, 1 year 6 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend sa cotation sur Euronext Paris en attendant un prochain communiqué. La société développe des traitements innovants contre les infections bactériennes Cotation Suspension Traitements Innovants PHAXIAM Therapeutics Infections Bactériennes
BRIEF published on 12/30/2024 at 17:50, 1 year 9 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
BRIEF published on 12/30/2024 at 17:50, 1 year 9 months ago PHAXIAM Therapeutics : résultats prometteurs de l’étude pilote PhagoDAIR PHAXIAM Therapeutics Étude PhagoDAIR Phages Anti-S. Aureus Phase II GLORIA Contrôle De L'infection
Published on 10/03/2026 at 02:35, 1 day 22 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 11 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 12 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 12 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/05/2026 at 00:05, 1 hour 20 minutes ago TerraMaster lance sa saison de mise à niveau du stockage avec jusqu’à 30 % de réduction à l’occasion des Prime Big Deal Days
Published on 10/04/2026 at 06:05, 19 hours 20 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 20 hours 10 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 9 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days 1 hour ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 17:45, 2 days 7 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 7 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 7 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 7 hours ago Aéroports de Paris SA - Calendrier financier 2027
